Vaccinex
Stock Forecast, Prediction & Price Target

Vaccinex Financial Estimates

Vaccinex Revenue Estimates

Vaccinex EBITDA Estimates

Vaccinex Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025
Revenue
 
% change YoY
$900K
 
N/A
$100K
 
-88.88%
$570K
 
470%
Avg: $142.7M
Low: $142.7M
High: $142.7M
avg. 24935.08%
Net Income
 
% change YoY
$-23.23M
 
N/A
$-19.72M
 
15.10%
$-20.25M
 
-2.68%
Avg: $119.76M
Low: $119.76M
High: $119.76M
avg. 691.38%
EBITDA
 
% change YoY
$-22.27M
 
N/A
$-19.60M
 
11.99%
$-19.74M
 
-0.72%
Avg: $-142.7M
Low: $-142.7M
High: $-142.7M
avg. -622.60%
EPS
 
% change YoY
-$170.04
 
N/A
-$97.59
 
42.60%
-$43.68
 
55.24%
Avg: $258.3
Low: $258.3
High: $258.3
avg. 691.34%
Operating Expenses
 
% change YoY
$23.39M
 
N/A
$20.00M
 
-14.46%
$23.45M
 
17.23%
Avg: $6.90B
Low: $6.90B
High: $6.90B
avg. 29330.15%

FAQ

What is Vaccinex stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 691.38% in 2025-2025.

We have gathered data from N/A analysts. Their low estimate is 119.76M, average is 119.76M and high is 119.76M.

What is Vaccinex stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 24935.08% in 2025-2025.

We have gathered data from 1 analysts. Their low revenue estimate is $142.7M, average is $142.7M and high is $142.7M.

What is Vaccinex stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 691.34% in 2025-2025.

We have gathered data from N/A analysts. Their low earnings per share estimate is $258.3, average is $258.3 and high is $258.3.